George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

Tue, 13th Feb 2024 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Citigroup raises GSK to 'buy' (neutral) - price target 2,100 (1,700) pence

----------

DZ Bank cuts fair value for AstraZeneca to 10,400 (11,000) pence - 'hold'

----------

Goldman Sachs cuts Unilever price target to 4,505 (4,580) pence - 'neutral'

----------

Goldman Sachs raises M&G price target to 249 (240) pence - 'buy'

----------

RBC cuts Glencore price target to 520 (540) pence - 'outperform'

----------

FTSE 250

----------

JPMorgan cuts ITV price target to 105 (106) pence - 'overweight'

----------

Goldman Sachs cuts SSP price target to 255 (260) pence - 'neutral'

----------

RBC starts Breedon with 'outperform' - price target 575 pence

----------

Jefferies cuts Primary Health Properties price target to 114 (122) pence - 'buy'

----------

SMALL CAP

----------

Shore Capital Markets lifts XPS Pensions to 'buy' from 'hold'

----------

Berenberg cuts ITM Power price target to 70 (80) pence - 'hold'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related...

24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application ...

24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jempe...

17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.